Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Glucose-Dependent Promoters for Dynamic Regulation of Metabolic Pathways.

Maury J, Kannan S, Jensen NB, Öberg FK, Kildegaard KR, Forster J, Nielsen J, Workman CT, Borodina I.

Front Bioeng Biotechnol. 2018 May 22;6:63. doi: 10.3389/fbioe.2018.00063. eCollection 2018.

2.

The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates.

Tsonkova VG, Sand FW, Wolf XA, Grunnet LG, Kirstine Ringgaard A, Ingvorsen C, Winkel L, Kalisz M, Dalgaard K, Bruun C, Fels JJ, Helgstrand C, Hastrup S, Öberg FK, Vernet E, Sandrini MPB, Shaw AC, Jessen C, Grønborg M, Hald J, Willenbrock H, Madsen D, Wernersson R, Hansson L, Jensen JN, Plesner A, Alanentalo T, Petersen MBK, Grapin-Botton A, Honoré C, Ahnfelt-Rønne J, Hecksher-Sørensen J, Ravassard P, Madsen OD, Rescan C, Frogne T.

Mol Metab. 2018 Feb;8:144-157. doi: 10.1016/j.molmet.2017.12.007. Epub 2017 Dec 19.

3.

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.

Alzrigat M, Párraga AA, Majumder MM, Ma A, Jin J, Österborg A, Nahi H, Nilsson K, Heckman CA, Öberg F, Kalushkova A, Jernberg-Wiklund H.

Oncotarget. 2017 Oct 20;8(61):103731-103743. doi: 10.18632/oncotarget.21909. eCollection 2017 Nov 28.

4.

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.

Alzrigat M, Párraga AA, Agarwal P, Zureigat H, Österborg A, Nahi H, Ma A, Jin J, Nilsson K, Öberg F, Kalushkova A, Jernberg-Wiklund H.

Oncotarget. 2017 Feb 7;8(6):10213-10224. doi: 10.18632/oncotarget.14378.

5.

Genome-wide profiling of histone H3 lysine 27 and lysine 4 trimethylation in multiple myeloma reveals the importance of Polycomb gene targeting and highlights EZH2 as a potential therapeutic target.

Agarwal P, Alzrigat M, Párraga AA, Enroth S, Singh U, Ungerstedt J, Österborg A, Brown PJ, Ma A, Jin J, Nilsson K, Öberg F, Kalushkova A, Jernberg-Wiklund H.

Oncotarget. 2016 Feb 9;7(6):6809-23. doi: 10.18632/oncotarget.6843.

6.

Plasma Membrane Abundance of Human Aquaporin 5 Is Dynamically Regulated by Multiple Pathways.

Kitchen P, Öberg F, Sjöhamn J, Hedfalk K, Bill RM, Conner AC, Conner MT, Törnroth-Horsefield S.

PLoS One. 2015 Nov 16;10(11):e0143027. doi: 10.1371/journal.pone.0143027. eCollection 2015.

7.

Establishing a synthetic pathway for high-level production of 3-hydroxypropionic acid in Saccharomyces cerevisiae via β-alanine.

Borodina I, Kildegaard KR, Jensen NB, Blicher TH, Maury J, Sherstyk S, Schneider K, Lamosa P, Herrgård MJ, Rosenstand I, Öberg F, Forster J, Nielsen J.

Metab Eng. 2015 Jan;27:57-64. doi: 10.1016/j.ymben.2014.10.003. Epub 2014 Oct 23.

8.

X-ray structure of human aquaporin 2 and its implications for nephrogenic diabetes insipidus and trafficking.

Frick A, Eriksson UK, de Mattia F, Oberg F, Hedfalk K, Neutze R, de Grip WJ, Deen PM, Törnroth-Horsefield S.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6305-10. doi: 10.1073/pnas.1321406111. Epub 2014 Apr 14.

9.

Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine.

Frykholm P, Pikwer A, Hammarskjöld F, Larsson AT, Lindgren S, Lindwall R, Taxbro K, Oberg F, Acosta S, Akeson J.

Acta Anaesthesiol Scand. 2014 May;58(5):508-24. doi: 10.1111/aas.12295. Epub 2014 Mar 5.

PMID:
24593804
10.

AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.

Eriksson A, Kalushkova A, Jarvius M, Hilhorst R, Rickardson L, Kultima HG, de Wijn R, Hovestad L, Fryknäs M, Öberg F, Larsson R, Parrow V, Höglund M.

Biochem Pharmacol. 2014 Jan 15;87(2):284-91. doi: 10.1016/j.bcp.2013.10.022. Epub 2013 Nov 4.

11.

CO2 permeability of cell membranes is regulated by membrane cholesterol and protein gas channels.

Itel F, Al-Samir S, Öberg F, Chami M, Kumar M, Supuran CT, Deen PM, Meier W, Hedfalk K, Gros G, Endeward V.

FASEB J. 2012 Dec;26(12):5182-91. doi: 10.1096/fj.12-209916. Epub 2012 Sep 10.

PMID:
22964306
12.

Recombinant production of the human aquaporins in the yeast Pichia pastoris (Invited Review).

Oberg F, Hedfalk K.

Mol Membr Biol. 2013 Feb;30(1):15-31. doi: 10.3109/09687688.2012.665503. Epub 2012 Aug 21. Review.

PMID:
22908994
13.

Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.

Dimberg LY, Dimberg A, Ivarsson K, Fryknäs M, Rickardson L, Tobin G, Ekman S, Larsson R, Gullberg U, Nilsson K, Öberg F, Wiklund HJ.

BMC Cancer. 2012 Jul 28;12:318. doi: 10.1186/1471-2407-12-318.

14.

Acoustical and perceptual influence of duplex stringing in grand pianos.

Öberg F, Askenfelt A.

J Acoust Soc Am. 2012 Jan;131(1):856-71. doi: 10.1121/1.3664049.

PMID:
22280708
15.

Improving recombinant eukaryotic membrane protein yields in Pichia pastoris: the importance of codon optimization and clone selection.

Öberg F, Sjöhamn J, Conner MT, Bill RM, Hedfalk K.

Mol Membr Biol. 2011 Sep;28(6):398-411. doi: 10.3109/09687688.2011.602219. Epub 2011 Jul 19.

PMID:
21770695
16.

Glycosylation increases the thermostability of human aquaporin 10 protein.

Öberg F, Sjöhamn J, Fischer G, Moberg A, Pedersen A, Neutze R, Hedfalk K.

J Biol Chem. 2011 Sep 9;286(36):31915-23. doi: 10.1074/jbc.M111.242677. Epub 2011 Jul 6.

17.

Polycomb target genes are silenced in multiple myeloma.

Kalushkova A, Fryknäs M, Lemaire M, Fristedt C, Agarwal P, Eriksson M, Deleu S, Atadja P, Osterborg A, Nilsson K, Vanderkerken K, Oberg F, Jernberg-Wiklund H.

PLoS One. 2010 Jul 9;5(7):e11483. doi: 10.1371/journal.pone.0011483.

18.

TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.

Wu S, Hultquist A, Hydbring P, Cetinkaya C, Oberg F, Larsson LG.

Exp Cell Res. 2009 Nov 1;315(18):3099-111. doi: 10.1016/j.yexcr.2009.09.009. Epub 2009 Sep 17.

PMID:
19766114
19.

Insight into factors directing high production of eukaryotic membrane proteins; production of 13 human AQPs in Pichia pastoris.

Oberg F, Ekvall M, Nyblom M, Backmark A, Neutze R, Hedfalk K.

Mol Membr Biol. 2009 May;26(4):215-27. doi: 10.1080/09687680902862085. Epub 2009 Apr 21.

PMID:
19384754
20.

Herbal melanin activates TLR4/NF-kappaB signaling pathway.

Oberg F, Haseeb A, Ahnfelt M, Pontén F, Westermark B, El-Obeid A.

Phytomedicine. 2009 May;16(5):477-84. doi: 10.1016/j.phymed.2008.10.008. Epub 2008 Dec 21.

PMID:
19103478
21.

Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.

Tshuikina M, Jernberg-Wiklund H, Nilsson K, Oberg F.

Exp Hematol. 2008 Dec;36(12):1673-1681. doi: 10.1016/j.exphem.2008.08.001. Epub 2008 Oct 15.

PMID:
18922617
22.

A lipidic-sponge phase screen for membrane protein crystallization.

Wöhri AB, Johansson LC, Wadsten-Hindrichsen P, Wahlgren WY, Fischer G, Horsefield R, Katona G, Nyblom M, Oberg F, Young G, Cogdell RJ, Fraser NJ, Engström S, Neutze R.

Structure. 2008 Jul;16(7):1003-9. doi: 10.1016/j.str.2008.06.003.

23.

Production, characterization and crystallization of the Plasmodium falciparum aquaporin.

Hedfalk K, Pettersson N, Oberg F, Hohmann S, Gordon E.

Protein Expr Purif. 2008 May;59(1):69-78. doi: 10.1016/j.pep.2008.01.004. Epub 2008 Jan 26.

PMID:
18295508
24.

Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.

Tshuikina M, Nilsson K, Oberg F.

Gene. 2008 Mar 15;410(2):259-67. doi: 10.1016/j.gene.2007.12.013. Epub 2008 Feb 1.

PMID:
18242011
25.

Exceptional overproduction of a functional human membrane protein.

Nyblom M, Oberg F, Lindkvist-Petersson K, Hallgren K, Findlay H, Wikström J, Karlsson A, Hansson O, Booth PJ, Bill RM, Neutze R, Hedfalk K.

Protein Expr Purif. 2007 Nov;56(1):110-20. Epub 2007 Aug 10.

PMID:
17869538
26.

STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines.

Fryknäs M, Dhar S, Oberg F, Rickardson L, Rydåker M, Göransson H, Gustafsson M, Pettersson U, Nygren P, Larsson R, Isaksson A.

Int J Cancer. 2007 Jan 1;120(1):189-95.

28.

IFN-gamma-induced upregulation of Fcgamma-receptor-I during activation of monocytic cells requires the PKR and NFkappaB pathways.

Kårehed K, Dimberg A, Dahl S, Nilsson K, Oberg F.

Mol Immunol. 2007 Jan;44(4):615-24. Epub 2006 Mar 3.

PMID:
16516295
29.

Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.

Lövborg H, Oberg F, Rickardson L, Gullbo J, Nygren P, Larsson R.

Int J Cancer. 2006 Mar 15;118(6):1577-80.

30.

Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells.

Dimberg LY, Dimberg AI, Ivarsson K, Strömberg T, Osterborg A, Nilsson K, Oberg F, Jernberg Wiklund H.

Blood. 2005 Aug 15;106(4):1346-54. Epub 2005 Apr 28.

PMID:
15860671
31.

Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828.

Gullbo J, Lövborg H, Dhar S, Lukinius A, Oberg F, Nilsson K, Björkling F, Binderup L, Nygren P, Larsson R.

Anticancer Drugs. 2004 Jan;15(1):45-54.

PMID:
15090743
32.

Retinoic acid-induced cell cycle arrest of human myeloid cell lines.

Dimberg A, Oberg F.

Leuk Lymphoma. 2003 Oct;44(10):1641-50. Review.

PMID:
14692514
33.
34.
35.

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.

Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gröndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jönssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME.

Nat Genet. 2002 Dec;32(4):666-9. Epub 2002 Oct 28.

PMID:
12402038
36.
37.
38.
39.

The role of RAR and RXR activation in retinoid-induced tissue factor suppression.

Tenno T, Botling J, Oberg F, Jossan S, Nilsson K, Siegbahn A.

Leukemia. 2000 Jun;14(6):1105-11.

40.

Induction of differentiation in U-937 and NB4 cells is associated with inhibition of tissue factor production.

Tenno T, Oberg F, Nilsson K, Siegbahn A.

Eur J Haematol. 1999 Aug;63(2):112-9.

PMID:
10480290
41.
42.

Serglycin expression during monocytic differentiation of U937-1 cells.

Kulseth MA, Mustorp SL, Uhlin-Hansen L, Oberg F, Kolset SO.

Glycobiology. 1998 Aug;8(8):747-53.

PMID:
9639535
43.

Tissue factor expression in human monocytic cell lines.

Tenno T, Botling J, Oberg F, Nilsson K, Siegbahn A.

Thromb Res. 1997 Oct 15;88(2):215-28.

PMID:
9361374
44.

Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18).

Johansson MW, Patarroyo M, Oberg F, Siegbahn A, Nilsson K.

J Cell Sci. 1997 May;110 ( Pt 9):1133-9.

46.

Tissue and differentiation specific expression on the endogenous retrovirus ERV3 (HERV-R) in normal human tissues and during induced monocytic differentiation in the U-937 cell line.

Larsson E, Venables P, Andersson AC, Fan W, Rigby S, Botling J, Oberg F, Cohen M, Nilsson K.

Leukemia. 1997 Apr;11 Suppl 3:142-4.

PMID:
9209323
47.

Cytokine-induced inhibition of Myc activity in monocytic cells.

Larsson LG, Bahram F, Wu S, Oberg F, Nilsson K, Lüscher B.

Curr Top Microbiol Immunol. 1997;224:191-200. No abstract available.

PMID:
9308242
49.

Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line.

Larsson E, Venables PJ, Andersson AC, Fan W, Rigby S, Botling J, Oberg F, Cohen M, Nilsson K.

Int J Cancer. 1996 Jul 29;67(3):451-6.

50.

Supplemental Content

Support Center